The Effect of Mandala Coloring on Depression, Anxiety and Quality of Life of Inpatients in a Psychiatric Clinic (Mandala)

September 28, 2025 updated by: reyhan eskiyurt
The aim of this study is to examine the effects of mandala coloring activity applied to individuals hospitalized in a psychiatric clinic with a diagnosis of anxiety and depression disorder on quality of life, psychological resilience and depression, anxiety and stress levels.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Introduction: It is stated that healthcare professional-patient interaction and patient activity improve clinical outcomes for patients with mental illness. When compared to psychosocial interventions, the most commonly used method in 49% of clinics was found to be artistic practices. It is stated that mandala painting has a calming and healing effect on the individual, facilitating psychological integration and personal meaning in life.

Objective: The aim of this study is to examine the effects of mandala coloring activity applied to individuals hospitalized in a psychiatric clinic with a diagnosis of anxiety and depression disorder on quality of life, psychological resilience and depression, anxiety and stress levels.

Method: The research will be conducted using a randomized controlled experimental research design. The research sample will consist of 50 patients in a university hospital psychiatry clinic. Research data will be collected using the Introductory Information Form, Depression-Anxiety-Stress Scale Short Form, Quality of Life Scale (SF-12), and Brief Resilience Scale. Patients diagnosed with anxiety and depression will undergo 8 sessions of mandala application. Data will be collected in two time periods before starting the mandala application and at the end of the 8-session application.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey (Türkiye), 06010
        • Ankara Yıldırım Beyazıt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Agreeing to participate in the study
  • Being 18 years of age or older
  • Diagnosed with anxiety and depression disorder

Exclusion Criteria:

  • Those who gave incomplete answers to the scales used in the study
  • Those with serious psychiatric symptoms (e.g. harming themselves or others, sedation)
  • Those who did not participate in the mandala coloring session
  • Those who did not agree to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention will be applied to the patients in the control group during the follow-up period, only data collection forms will be applied.
Experimental: Experimental (mandala coloring)
Mandala group will participate in 8 sessions of mandala application. Mandala Coloring Application will be applied to the Intervention group 2-3 times a week for 3 weeks. Mandala application will be done by the researcher and feedback about the mandala will be received from the patients at the end of each session. Data collection forms will be applied before the mandala painting application starts and after the mandala painting application ends (after the 8th session).
Mandala group will participate in 8 sessions of mandala application. Mandala Coloring Application will be applied to the Intervention group 2-3 times a week for 3 weeks. Mandala application will be done by the researcher and feedback about the mandala will be received from the patients at the end of each session. Data collection forms will be applied before the mandala painting application starts and after the mandala painting application ends (after the 8th session).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression-Anxiety-Stress Scale
Time Frame: 3 week
The scale, developed to determine the depression, anxiety and stress levels of individuals, consists of 21 items and 3 subscales. Depression-Anxiety-Stress Scale is a 4-point Likert-type measurement tool (0-not suitable for me and 3-completely suitable for me). The Turkish validity and reliability study of Depression-Anxiety-Stress Scale was conducted. High scores on the scale reveal which of the depression, anxiety and stress sub-dimensions the individual is experiencing problems with.
3 week
Quality of Life Scale
Time Frame: 3 week
Quality of life scale (The SF-12) has two summary scales: physical component and mental component. The physical component summary scale consists of physical function, physical role, body pain and general health subscales, and the mental component summary consists of vitality, social function, emotional role and mental health subscales. The score of each subscale varies between 0-100 and the score is directly proportional to the quality of life. The Turkish validity and reliability study of the scale was conducted. Minimum and maximum scores can range from 0-100 from the scale. High scores indicate high quality of life.
3 week
Brief Psychological Resilience Scale
Time Frame: 3 week
Brief Psychological Resilience Scale is a 5-point Likert-type, 6-item, self-report measurement tool. After the reverse-coded items in the scale are translated, high scores indicate high psychological resilience. The Turkish validity and reliability study of the scale.
3 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Reyhan Eskiyurt, Yıldırım Beyazıt U

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2025

Primary Completion (Actual)

September 28, 2025

Study Completion (Actual)

September 28, 2025

Study Registration Dates

First Submitted

February 18, 2025

First Submitted That Met QC Criteria

February 18, 2025

First Posted (Actual)

February 21, 2025

Study Record Updates

Last Update Posted (Estimated)

September 30, 2025

Last Update Submitted That Met QC Criteria

September 28, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • YBU-378

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Mandala coloring

Subscribe